Polaris Venture Management Co. V, L.L.C.
Boston, MA · CIK 1439589 · 13F filing filed 2021-11-12
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyBoston, MA
$14.1m
reported value
-77.4% vs Q2 2021
6positions
100.0%in top 10
0 new
0 added
0 reduced
1 sold out
vs Q2 2021
Holdings, Q3 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| LYRA THERAPEUTICS INC LYRA | $10.0m71.28% | Unchanged |
| X4 PHARMACEUTICALS INC COM | $1.6m11.70% | Unchanged |
| ATYR PHARMA INC LIFE | $1.2m8.42% | Unchanged |
| DARE BIOSCIENCE INC COM | $545.0k3.87% | Unchanged |
| GENOCEA BIOSCIENCES INC GNCAQ | $379.0k2.69% | Unchanged |
| PULMATRIX INC PULM | $288.0k2.04% | Unchanged |
Sold out since Q2 2021
| Security | Value then |
|---|---|
| FATE THERAPEUTICS INC FATE | $49.5m569.9k shares |